08:46 AM EDT, 10/29/2026 (MT Newswires) -- Merck KGaA (MRK.F) opened a 300 million-euro bioprocessing production center in Daejeon, South Korea, to boost regional capacity for Asia-Pacific biopharma manufacturers. The 44,500-square-meter facility will manufacture critical materials and tools used for biologic medicine production, supporting early process development through commercial-scale operations, the German science and technology company said Thursday. The site will also utilize solar energy, a heat-pump system, energy recovery in air handling units, and rainwater recycling to improve energy and water efficiency.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.